Skip to content
OpenCapital
Get started

Travere Therapeutics, Inc. TVTX EV / sales

EV / sales at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
9×-1.9×
LQD
Liquidia CorporationLQDA
10.8×-66.6×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
2.7×-4.0×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
28.9×-18.5×
PTC Therapeutics logo
PTC TherapeuticsPTCT
6.3×+4.6×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
3.8×-0.6×

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K—
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.2B+72.3%

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Calculated from Travere Therapeutics, Inc.’s reported figures.

enterprise value/total revenue=5×

Based on the most recent quarter.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s EV / sales?
Travere Therapeutics, Inc. (TVTX) reported EV / sales of 5× in Q1 2026.
How has Travere Therapeutics, Inc.'s EV / sales changed year-over-year?
Travere Therapeutics, Inc.'s EV / sales decreased by 15.6% year-over-year, from 5.9× to 5×.
What is the long-term trend for Travere Therapeutics, Inc.'s EV / sales?
Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s EV / sales has grown at a -2.3% compound annual growth rate (CAGR), from 7.5× to 6.8×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.